A new trading day began on Tuesday, with Jasper Therapeutics Inc (NASDAQ: JSPR) stock price up 8.58% from the previous day of trading, before settling in for the closing price of $5.13. JSPR’s price has ranged from $3.13 to $26.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 54.53% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -7.13%. With a float of $12.59 million, this company’s outstanding shares have now reached $15.02 million.
In an organization with 64 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 24.53%, operating margin of -7067.21%, and the pretax margin is 1169.34%.
Jasper Therapeutics Inc (JSPR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Jasper Therapeutics Inc is 16.21%, while institutional ownership is 74.03%. The most recent insider transaction that took place on Dec 12 ’24, was worth 19,899. In this transaction Chief Operating Officer of this company sold 900 shares at a rate of $22.11, taking the stock ownership to the 25,009 shares. Before that another transaction happened on Dec 12 ’24, when Company’s Executive Officer proposed sale 900 for $22.47, making the entire transaction worth $20,223.
Jasper Therapeutics Inc (JSPR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -7.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.15% during the next five years compared to 54.53% growth over the previous five years of trading.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Here are Jasper Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.25, a number that is poised to hit -1.33 in the next quarter and is forecasted to reach -5.27 in one year’s time.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.32 million. That was inferior than the volume of 0.38 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 34.95%.
During the past 100 days, Jasper Therapeutics Inc’s (JSPR) raw stochastic average was set at 62.09%, which indicates a significant increase from 58.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.39% in the past 14 days, which was lower than the 78.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.05, while its 200-day Moving Average is $11.96. However, in the short run, Jasper Therapeutics Inc’s stock first resistance to watch stands at $5.84. Second resistance stands at $6.10. The third major resistance level sits at $6.49. If the price goes on to break the first support level at $5.18, it is likely to go to the next support level at $4.79. The third support level lies at $4.53 if the price breaches the second support level.
Jasper Therapeutics Inc (NASDAQ: JSPR) Key Stats
With a market capitalization of 83.67 million, the company has a total of 15,022K Shares Outstanding. Currently, annual sales are 0 K while annual income is -71,270 K. The company’s previous quarter sales were 0 K while its latest quarter income was -21,240 K.
